Pacer Advisors »

Zenas Biopharma shares owned by Pacer Advisors

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $16k 626 25.56

More positions owned by Pacer Advisors

NVIDIA Corp Common Stock - Domestic (NVDA)
Bristol-Myers Squibb Common Stock - Domestic (BMY)
Altria Group Common Stock - Domestic (MO)
Comcast Corp Common Stock - Domestic (CMCSA)
Apple Common Stock - Domestic (AAPL)
Booking Holdings Common Stock - Domestic (BKNG)
Verizon Communications Common Stock - Domestic (VZ)
Pfizer Common Stock - Domestic (PFE)
At&t Common Stock - Domestic (T)
Qualcomm Common Stock - Domestic (QCOM)
Gilead Sciences Common Stock - Domestic (GILD)
HCA Healthcare Common Stock - Domestic (HCA)
Lowe's Cos Common Stock - Domestic (LOW)
Uber Technologies Common Stock - Domestic (UBER)
Newmont Corp Common Stock - Domestic (NEM)

View all positions for Pacer Advisors

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
BlackRock
Capital Research and Management Company - Division 3
Polar Capital Holdings
Royalty Pharma Sub-Manager
Fairmount Funds Management
NVP Associates
Wellington Management Company
State Street Corporation
Vanguard Capital Management
Bank of America Corporation

View all funds holding Zenas Biopharma